Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside of the brain and spinal cord—are damaged, it can cause pain and ...

Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

However, shock wave therapy is still a new treatment option for diabetic neuropathy. Additional data is needed before complete statistics are available. In one small study from 2022, 73% of ...

A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...

At Regenerative Neuropathy, highly trained doctors are using a cutting-edge treatment and successfully ... also receive a free copy of Dr. Weber’s new book, “The Regenerative Effect.” ...

University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

"Neuropathy is inflammation of the nervous ... causing doctors to dial back their life-saving medication. "We were seeing inferior survival because of the dose reductions. So, not only is this ...

"Neuropathy is inflammation of the nervous system ... causing doctors to dial back their life-saving medication. "We were seeing inferior survival because of the dose reductions. So, not only is this ...